Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
7. Medtronic notches milestones in CoreValve TAVI research, adds lower-risk patients
Medtech titan Medtronic closes enrollment in its U.S. pivotal trial for the CoreValve transcatheter aortic valve implantation system and lands FDA approval to expand a separate CoreValve trial to lower-risk patients.
6. Edwards Lifesciences insiders keep selling
No Edwards Lifesciences insiders have bought company stock since April 2012, during which time EW shares have gained nearly 40%.
5. The weight loss pacemaker: MassDevice Q&A with EnteroMedics
EnteroMedics CEO Mark Knudson and CFO Greg Lea tells MassDevice.com about the company’s Maestro weight loss pacemaker and how a twist on neuromodulation may help patients eat less and feel full without anatomy-altering surgery.
4. ESC 2012: Renal denervation a “fountain of youth,” researchers say
Doctors and researchers at the European Society of Cardiology Conference crow about the potential benefits of renal denervation in restoring youth to stiffened arteries, treating hypertension and maybe even benefiting patients with heart failure.
3. St. Jude announces layoffs, restructuring and an executive shuffle following bleak quarter
Following a tough 2nd quarter, St. Jude Medical plans to cut about 300 positions as it restructures its product divisions into separate implantable electronics and cardiovascular & ablation divisions, announcing an executive shakeup along the way.
2. Boston Scientific shakeup: Layoffs and restructuring ahead for cardiac business
Medical device giant Boston Scientific expects an untold number of layoffs in the next few months and the company will its cardiac device businesses into separate CRM and stent divisions.
1. Medical Device Companies: Medtech’s best/worst valued stocks
A comparison of asset values and share values for medical device companies from theMassDevice Big 100 database.
